Plexium Revenue and Competitors

Location

$165M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Plexium's estimated annual revenue is currently $20.5M per year.(i)
  • Plexium's estimated revenue per employee is $201,000
  • Plexium's total funding is $165M.

Employee Data

  • Plexium has 102 Employees.(i)
  • Plexium grew their employee count by -3% last year.

Plexium's People

NameTitleEmail/Phone
1
Head Technology DevelopmentReveal Email/Phone
2
EVP, Drug DiscoveryReveal Email/Phone
3
VP, BiologyReveal Email/Phone
4
EVP, Corporate Business DevelopmentReveal Email/Phone
5
Senior Director Proteomics PlatformReveal Email/Phone
6
Director, BiologyReveal Email/Phone
7
Director, Project Management AnalyticsReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Director, Software EngineeringReveal Email/Phone
10
Director, Facilities & EHSReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$84.8M42224%N/AN/A
#2
$0.4M20%N/AN/A
#3
$32M1593%N/AN/A
#4
$35M1213%$62.5MN/A
#5
$30.2M15018%N/AN/A
#6
$135.3M6730%N/AN/A
#7
$110.3M549N/AN/AN/A
#8
$60.1M299-4%N/AN/A
#9
$554.8M17252%N/AN/A
#10
$10.5M524%N/AN/A
Add Company

What Is Plexium?

Plexium is a pharmaceutical company developing first-in-class therapeutics by modulating E3 ligases

keywords:N/A

$165M

Total Funding

102

Number of Employees

$20.5M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Plexium News

2022-03-30 - Plexium Announces Participation of its CEO, Percival Barretto ...

(Plexium), a leading next-generation targeted protein degradation (TPD) company, today announced that Plexium President & CEO, Percival Barretto...

2022-03-30 - RA, Atlas-backed biotech spins up with $110M in pursuit of ...

In the fall, it backed Avilar Therapeutics and two months ago, it helped pour $102 million into Plexium, the startup headed by Astellas vet...

2021-01-25 - Plexium Announces $35m Financing to Advance Pipeline of Novel Protein Degraders

Plexium Announces $35m Financing to Advance Pipeline of Novel Protein Degraders Company also announces appointment of biotech veteran Mike Grey as Chairman of the Board

2021-01-21 - Plexium Raises $35M in Funding

Plexium, Inc., a San Diego, CA-based biotech company focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, completed a $35M financing. The round was led by Lux Capital and Pivotal BioVentures, with participation from The Col ...

2021-01-21 - Plexium Finds $35M More For Biotech Efforts

San Diego-based Plexium, a biotech startup focused on discovering and developing protein degrading therapeutics directed towards historically challenging drug targets, announced this morning that it has raised $35M in a financing round. The funding is an extension of the company's October 2019 S ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.8M10220%N/A
#2
$14.8M1024%N/A
#3
$12.2M102-8%N/A
#4
$27.5M102-2%N/A
#5
$15.8M10231%N/A